|
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 5152-5162.
Prepublished online as a Blood First Edition Paper on March 19, 2008; DOI 10.1182/blood-2007-10-116889.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide–induced cell death in myeloma
Alejo A. Morales1,
Delia Gutman1,
Kelvin P. Lee2, and
Lawrence H. Boise1
1 Microbiology and Immunology and The Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, FL; and
2 Department of Immunology and Medicine, Roswell Park Cancer Institute, Buffalo, NY
The use of arsenic trioxide (ATO) to treat multiple myeloma (MM) is supported by preclinical studies as well as several phase 2 studies, but the precise mechanism(s) of action of ATO has not been completely elucidated. We used gene expression profiling to determine the regulation of apoptosis-related genes by ATO in 4 MM cell lines and then focused on Bcl-2 family genes. ATO induced up-regulation of 3 proapoptotic BH3-only proteins (Noxa, Bmf, and Puma) and down-regulation of 2 antiapoptotic proteins Mcl-1 and Bcl-XL. Coimmunoprecipitation demonstrated that Noxa and Puma bind Mcl-1 to release Bak and Bim within 6 hours of ATO addition. Bak and Bim are also released from Bcl-XL. Silencing of Bmf, Noxa, and Bim significantly protected cells from ATO-induced apoptosis, while Puma silencing had no effect. Consistent with a role for Noxa inhibition of Mcl-1, the Bad-mimetic ABT-737 synergized with ATO in the killing of 2 MM lines. Finally, Noxa expression was enhanced by GSH depletion and inhibited by increasing GSH levels in the cells. Understanding the pattern of BH3-only protein response should aid in the rational design of arsenic-containing regimens.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. C. Platanias
Biological Responses to Arsenic Compounds
J. Biol. Chem.,
July 10, 2009;
284(28):
18583 - 18587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Morales, D. Gutman, P. J. Cejas, K. P. Lee, and L. H. Boise
Reactive Oxygen Species Are Not Required for an Arsenic Trioxide-induced Antioxidant Response or Apoptosis
J. Biol. Chem.,
May 8, 2009;
284(19):
12886 - 12895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Matulis, A. A. Morales, L. Yehiayan, C. Croutch, D. Gutman, Y. Cai, K. P. Lee, and L. H. Boise
Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line
Mol. Cancer Ther.,
May 1, 2009;
8(5):
1197 - 1206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hauck, B. H. Chao, J. Litz, and G. W. Krystal
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
Mol. Cancer Ther.,
April 1, 2009;
8(4):
883 - 892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. VanBrocklin, M. Verhaegen, M. S. Soengas, and S. L. Holmen
Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma
Cancer Res.,
March 1, 2009;
69(5):
1985 - 1994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Surgucheva, V. I. Shestopalov, and A. Surguchov
Effect of {gamma}-Synuclein Silencing on Apoptotic Pathways in Retinal Ganglion Cells
J. Biol. Chem.,
December 26, 2008;
283(52):
36377 - 36385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lunghi, N. Giuliani, L. Mazzera, G. Lombardi, M. Ricca, A. Corradi, A. M. Cantoni, L. Salvatore, R. Riccioni, A. Costanzo, et al.
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
Blood,
September 15, 2008;
112(6):
2450 - 2462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
